---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-024228"
form_type: "8-K"
ticker: "JAGX"
cik: "0001585608"
company_name: "Jaguar Health, Inc."
filed_at: "2025-02-20T23:59:59+00:00"
generated_at: "2026-05-26T08:51:21.036448+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Jaguar Health extends maturity of $6.22M secured note to Jan 20, 2026

## Summary
- Note originally issued Jan 19, 2021; maturity extended from undated to Jan 20, 2026.
- Principal amount remains $6,220,812.50; no other terms changed publicly.
- Amendment dated Feb 13, 2025 between Jaguar Health, Napo Pharma, and Streeterville Capital.
- Extension provides additional time to repay; no default or acceleration mentioned.

## SEC filing metadata
- accession: 0000950170-25-024228
- form_type: 8-K
- ticker: JAGX
- cik: 0001585608
- company_name: Jaguar Health, Inc.
- filed_at: 2025-02-20T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/0000950170-25-024228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1585608/000095017025024228/jagx-20250219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-024228
- JSON: https://secwatch.observer/filing/0000950170-25-024228.json
- Plain text: https://secwatch.observer/filing/0000950170-25-024228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.